APA

Sillaire-Houtmann I., Bonafous J., Veyre A., Mestas D., D'Incan M., Moins N., Kemeny J., Chossat F. & Bacin F. (20040312). [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. : Journal francais d'ophtalmologie.

Chicago

Sillaire-Houtmann I, Bonafous J, Veyre A, Mestas D, D'Incan M, Moins N, Kemeny J-L, Chossat F and Bacin F. 20040312. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. : Journal francais d'ophtalmologie.

Harvard

Sillaire-Houtmann I., Bonafous J., Veyre A., Mestas D., D'Incan M., Moins N., Kemeny J., Chossat F. and Bacin F. (20040312). [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. : Journal francais d'ophtalmologie.

MLA

Sillaire-Houtmann I, Bonafous J, Veyre A, Mestas D, D'Incan M, Moins N, Kemeny J-L, Chossat F and Bacin F. [Phase 2 clinical study of 123I-N-(2-diethylaminoethyl)-2-iodobenzamide in the diagnostic of primary and metastatic ocular melanoma]. : Journal francais d'ophtalmologie. 20040312.